SCHEMBL24299042

SCHEMBL24299042

Cc1cccc(C)c1-c1cc(OCC(N)CC(C)(C)O)nc(NSc2cccc(C(=O)O)c2)n1

nearest known ligand 0.31

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.30
MITF O75030 1/20 0.30
NFKB1 P19838 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
PAX8 Q06710 1/20 0.30
KLF5 Q13887 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
SYK P43405 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24323223 0.94 SYK (0.32) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298126 0.94 SYK (0.32) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24324763 0.93 NPC1 (0.31) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24324602 0.92 ALKBH2 (0.31) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298196 0.92 MEN1 (0.30) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298904 0.91 LOXL2 (0.31)
SCHEMBL24324181 0.89 SYK (0.31) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298181 0.89 NPC1 (0.33) NPC1RAB9ASMN1; SMN2SYK
SCHEMBL24298810 0.88 AAK1 (0.34) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL22509294 0.88 AAK1 (0.34) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076621-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed